Last update May 2, 2022
Very Low Risk
It is a glycoside-sulphate derivative (sucrose) plus aluminum. It is indicated in peptic ulcer and chronic gastritis. Oral administration two to six times a day.
At latest update no published data on excretion into breastmilk were found.
Pharmacokinetic data (virtually non-absorbed with a high molecular weight) make it very unlikely the excretion into breastmilk in significant amounts, which in addition it would not be absorbed through the infant's intestine.
Medication with authorized use on infants.
Several medical societies and expert authors consider the use of this medication possible during breastfeeding. (Hale, LactMed, Thélin 2022, Briggs 2015, Schaefer 2015, Mahadevan 2006, Richter 2005, Hagemann 1998, Broussard 1998)
A cream with sucralfate, zinc, and copper has been used to treat nipple cracks. (Talaee 2021)
We do not have alternatives for Sucralfate since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2012 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM